-+ 0.00%
-+ 0.00%
-+ 0.00%

SILO PHARMA’S SP-26 KETAMINE IMPLANT MEETS ALL ENDPOINTS IN FIBROMYALGIA STUDY

Reuters·04/30/2025 12:11:00

Please log in to view news